Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
08 März 2024 - 1:00PM
Augmedix (Nasdaq: AUGX), a healthcare technology company that
delivers industry-leading, ambient medical documentation and data
solutions, announced today it will release fourth quarter and full
year 2023 results after the market closes on Monday, March 18,
2024. Following the release, management will host a conference call
and audio webcast to review results and provide a brief business
and outlook update that same day at 1:30 p.m. PT / 4:30 p.m. ET.
- Live conference
call: 877-407-3982 (Toll-Free) and 201-493-6780
(International)
- Live webcast:
https://viavid.webcasts.com/starthere.jsp?ei=1656407&tp_key=3507378dc0
An archived replay will be available following
the call on Augmedix’s IR website at https://ir.augmedix.com/.
About Augmedix
Augmedix (Nasdaq: AUGX) delivers
industry-leading, ambient medical documentation and data solutions
to healthcare systems, physician practices, hospitals, and
telemedicine practitioners.
Augmedix is on a mission to help clinicians and
patients form a human connection by seamlessly integrating our
technology at the point of care. Augmedix’s proprietary platform
digitizes natural clinician-patient conversations, which are
converted into comprehensive medical notes and structured data in
real time. The company’s platform uses automatic speech
recognition, and natural language processing, including large
language models, to generate accurate and timely medical notes that
are transferred into the EHR.
Augmedix’s products relieve clinicians of
administrative burden, in turn, reducing burnout, increasing
clinician efficiency and improving patient access. Through
Augmedix’s proprietary platform and bi-directional communication
channel, Augmedix is ideally suited to serve as the vehicle for
change at the point of care.
Augmedix is headquartered in San Francisco, CA,
with offices around the world. To learn more, visit
www.augmedix.com.
Contact Information
Investors:Matt Chesler, CFAFNK IR(646)
809-2183augx@fnkir.cominvestors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024